Literature DB >> 3618300

Adult occurrence of medulloblastoma.

J R Farwell, J T Flannery.   

Abstract

We analyze a series of 44 medulloblastomas in patients aged 20 and older, listed in the Connecticut Tumor Registry. Average age was 34.1 years. Incidence was 0.058 per 100,000 per year. Headache and ataxia were the most frequent presenting complaints. Findings at diagnosis most often were papilloedema, cranial nerve palsies, and cerebellar dysfunction. Treatments included operation (15%), radiation (7%), and operation plus radiation (60%). Probability of survival at one year was 0.62; at five years, 0.26. Survival with operation and radiation was superior to survival with other courses of treatment. Extracranial metastases to the spinal cord, the bones, and the pleura occurred in 27% of cases. For the first two years from diagnosis, survival in this series was significantly better than survival in the contemporary series of children with medulloblastoma. At five years and ten years, survival in adults and children was comparable.

Entities:  

Mesh:

Year:  1987        PMID: 3618300     DOI: 10.1007/bf01419496

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  6 in total

1.  MEDULLOBLASTOMA IN ADULTS. CLINICAL OBSERVATIONS ON A SERIES OF 29 CASES.

Authors:  G BORGHI; R CHIORINO
Journal:  Neurochirurgia (Stuttg)       Date:  1964-02

2.  Cerebellar medulloblastoma in adults.

Authors:  E B SPITZ; H A SHENKIN; F C GRANT
Journal:  Arch Neurol Psychiatry       Date:  1947-04

3.  Cerebellar medulloblastomata in adults: review of 18 cases.

Authors:  J Miles; Y S Bhandari
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-04       Impact factor: 10.154

4.  Extensive advanced maturation of medulloblastoma to astrocytoma and ependymoma.

Authors:  I Feigin; F Epstein; J Mangiardi
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

5.  Cerebellar medulloblastoma in adults.

Authors:  P G Hughes
Journal:  J Neurosurg       Date:  1984-05       Impact factor: 5.115

6.  Medulloblastoma in childhood: an epidemiological study.

Authors:  J R Farwell; G J Dohrmann; J T Flannery
Journal:  J Neurosurg       Date:  1984-10       Impact factor: 5.115

  6 in total
  8 in total

Review 1.  Extracranial metastases of medulloblastoma in adults: literature review.

Authors:  S Rochkind; I Blatt; M Sadeh; Y Goldhammer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

Review 2.  Medulloblastoma in late adults: report of two cases and critical review of the literature.

Authors:  L Cervoni; A Maleci; M Salvati; R Delfini; G Cantore
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

3.  Etoposide-carboplatin association as 'emergency' up-front chemotherapy in a case of life-threatening adult medulloblastoma.

Authors:  G Zona; N de Tribolet; G Pizzolato; P Y Dietrich
Journal:  J Neurooncol       Date:  1998-09       Impact factor: 4.130

4.  Adult medulloblastoma: review of 13 cases with emphasis on MRI.

Authors:  R L Becker; A D Becker; D F Sobel
Journal:  Neuroradiology       Date:  1995-02       Impact factor: 2.804

5.  Medulloblastoma in adults: a series from Brazil.

Authors:  Suzana M F Malheiros; Clélia M R Franco; João N Stávale; Adrialdo J Santos; Lia R R Borges; Maria P Pelaez; Fernando A P Ferraz; Alberto A Gabbai
Journal:  J Neurooncol       Date:  2002-12       Impact factor: 4.130

Review 6.  Cerebellar medulloblastomas in adults.

Authors:  I H Tekkök; T Süzer; T Ozgen; A Erbengi
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

7.  Medulloblastoma in children and in adults: a comparative study.

Authors:  A Maleci; L Cervoni; R Delfini
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

8.  Adult medulloblastoma: A rare case report and literature review.

Authors:  Ahmad Faried; Muhammad A Pribadi; Sheila Sumargo; Muhammad Z Arifin; Bethy S Hernowo
Journal:  Surg Neurol Int       Date:  2016-07-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.